Deploys growth capital into software and healthcare services across Europe and North America, prioritizing scalable business models and revenue efficiency. Sarah Jane Maidens is an investor and former operating executive who blends corporate development experience with hands-on portfolio oversight, sourcing cross-border deals, driving commercial acceleration and selective M&A. Frequently serves on boards and advises management teams on governance, go-to-market strategy and capital structure optimization.
Deploys growth capital into software and healthcare services across Europe and North America, prioritizing scalable business models and revenue efficiency. Sarah Jane Maidens is an investor and former operating executive who blends corporate development experience with hands-on portfolio oversight, sourcing cross-border deals, driving commercial acceleration and selective M&A. Frequently serves on boards and advises management teams on governance, go-to-market strategy and capital structure optimization.
Focuses on growth-stage software and healthcare services across Europe and North America, prioritizing scalable, revenue-efficient business models and durable unit economics. Combines corporate-development rigor with hands-on portfolio stewardship, sourcing cross-border opportunities, accelerating commercial motion, and executing selective M&A to create scale. Prefers active board-level engagement to optimize governance, go-to-market and capital structure. Targets multi-year, value-oriented growth with disciplined downside protection through staged capital, performance-linked milestones and operational KPIs.
Focuses on growth-stage software and healthcare services across Europe and North America, prioritizing scalable, revenue-efficient business models and durable unit economics. Combines corporate-development rigor with hands-on portfolio stewardship, sourcing cross-border opportunities, accelerating commercial motion, and executing selective M&A to create scale. Prefers active board-level engagement to optimize governance, go-to-market and capital structure. Targets multi-year, value-oriented growth with disciplined downside protection through staged capital, performance-linked milestones and operational KPIs.
| Trades 56 | Longs Won 29/56 51% | Profit Factor 1.59 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $4.56M |
| Average Win $3.56M | Best Trade (May 26) $17.64M | Sharpe Ratio -0.3 |
| Average Loss -$2.41M | Worst Trade (May 28) -$11.63M | Z-Score 0.14 (11.5%) |
| Commissions $0 | Avg. Trade Length 9m 2w 1d | Expectancy $686,028.66 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | 0.32% |
| Consecutive Losing Trades | 344 | 310 | 275 | 241 | 206 | 172 | 138 | 103 | 69 | 34 |